C07D 475/02
Heterocyclic compounds containing pteridine ring systems: with an oxygen atom directly attached
Official title: with an oxygen atom directly attached in position 4
C07D475/02 (Heterocyclic compounds containing pteridine ring systems: with an oxygen atom directly attached) appears on 331 US grants and 309 published applications in this corpus.
Search patents in C07D- Granted patents
- 331
- Published applications
- 309
- Assignees
- 221
- Inventors
- 880
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 10 | 0 |
| 1977 | 0 | 0 |
| 1978 | 3 | 0 |
| 1979 | 3 | 0 |
| 1980 | 3 | 0 |
| 1981 | 1 | 0 |
| 1982 | 2 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 4 | 0 |
| 1986 | 3 | 0 |
| 1987 | 5 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 3 | 0 |
| 1991 | 8 | 0 |
| 1992 | 4 | 0 |
| 1993 | 7 | 0 |
| 1994 | 11 | 0 |
| 1995 | 8 | 0 |
| 1996 | 3 | 0 |
| 1997 | 5 | 0 |
| 1998 | 8 | 0 |
| 1999 | 4 | 0 |
| 2000 | 5 | 0 |
| 2001 | 11 | 2 |
| 2002 | 11 | 8 |
| 2003 | 5 | 13 |
| 2004 | 4 | 9 |
| 2005 | 9 | 5 |
| 2006 | 3 | 12 |
| 2007 | 5 | 7 |
| 2008 | 5 | 8 |
| 2009 | 2 | 7 |
| 2010 | 7 | 18 |
| 2011 | 7 | 9 |
| 2012 | 8 | 12 |
| 2013 | 12 | 14 |
| 2014 | 10 | 17 |
| 2015 | 17 | 24 |
| 2016 | 18 | 14 |
| 2017 | 7 | 16 |
| 2018 | 9 | 16 |
| 2019 | 14 | 20 |
| 2020 | 11 | 15 |
| 2021 | 11 | 16 |
| 2022 | 7 | 10 |
| 2023 | 8 | 9 |
| 2024 | 14 | 9 |
| 2025 | 8 | 16 |
| 2026 | 4 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Nitrogen-branched non-linear pegylated lipid containing a tertiary amine and application thereof18 Aug 2026US 12,708,675 B2Xiamen Sinopeg Biotech Co., Ltd.
- Pharmaceutically acceptable salts of sepiapterin26 May 2026US 12,637,465 B2PTC Therapeutics MP, Inc.
- Folate salts for medical use12 May 2026US 12,622,913 B2Aprofol AG
- Nanomaterials containing constrained lipids and uses thereof10 Mar 2026US 12,569,438 B2Georgia Tech Research Corporation
- Pteridinone compounds and uses thereof12 Aug 2025US 12,384,790 B2Vertex Pharmaceuticals Incorporated
- Pharmaceutically acceptable salts of sepiapterin3 Sep 2026US 2026/0258045 A1PTC Therapeutics MP, Inc.
- Nanomaterials containing constrained lipids and uses thereof13 Aug 2026US 2026/0232587 A1Georgia Tech Research Corporation
- Alpha polyglutamated tetrahydrofolates and uses thereof19 Feb 2026US 2026/0048054 A1L.E.A.F. Holdings Group LLC
- Cryptophycin compounds and conjugates thereof4 Dec 2025US 2025/0368632 A1UniversitäT Bielefeld
- Composition for cancer diagnosis targeting tumor and/or tumor microenvironment and use thereof4 Sep 2025US 2025/0275943 A1
Most cited
By later US patents
- Lipid formulation340US 8,158,601 B2Alnylam Pharmaceuticals, Inc. · 2012
- Nucleosidic and non-nucleosidic folate conjugates297US 6,335,434 B12002
- Kinase inhibitors175US 6,831,175 B2Abbott Laboratories · 2004
- Lipid formulation126US 8,802,644 B2Tekmira Pharmaceuticals Corporation · 2014
- Compounds for inhibition of ceramide-mediated signal transduction117US 6,323,201 B1The Regents of the University of California · 2001